Statement of Cash Flows	8 Months Ended
	Dec. 31, 2020 USD ($)
Cash flows from operating activities:
Net loss	$ (1,784,919)
Adjustments to reconcile net loss to cash used in operating activities:
Interest earned in Trust Account	(1,585)
Unrealized losses on marketable securities held in Trust Account	1,050
Change in fair value of warrants	1,747,208
Changes in operating assets and liabilities
Change in prepaid expenses	(471,561)
Change in due to sponsor	5,000
Deferred offering cost
Change in accounts payable	23,382
Net cash used in operating activities	(481,425)
Cash flows from investing activities:
Investment of cash in Trust Account	(201,250,000)
Net cash used by operating activities	(201,250,000)
Cash flows from financing activities
Repayment of note payable borrowings	(141,134)
Proceeds from sale of Class A common stock to public	197,225,000
Proceeds from sale of private placement units	6,325,000
Payment of deferred offering costs	(259,901)
Net cash provided by financing activities	203,198,965
Net change in cash	1,417,540
Cash at beginning of period
Cash at end of period	1,417,540
Non-cash investing and financing activities:
Payment of deferred offering cost directly by related party	(166,134)
Purchase of common stock by Sponsor	25,000
Initial value of common stock subject to redemption	$ 201,250,535